AR052763A1 - TETRASUBSTITUID DERIVATIVES OF IMIDAZOL AS MODULATORS OF THE CANNABINOID CB1 RECEIVER WITH A HIGH SELECTIVITY FOR THE RECEIVER SUBTIPE CB1 / CB2. PHARMACEUTICAL COMPOSITIONS - Google Patents

TETRASUBSTITUID DERIVATIVES OF IMIDAZOL AS MODULATORS OF THE CANNABINOID CB1 RECEIVER WITH A HIGH SELECTIVITY FOR THE RECEIVER SUBTIPE CB1 / CB2. PHARMACEUTICAL COMPOSITIONS

Info

Publication number
AR052763A1
AR052763A1 ARP050102138A AR052763A1 AR 052763 A1 AR052763 A1 AR 052763A1 AR P050102138 A ARP050102138 A AR P050102138A AR 052763 A1 AR052763 A1 AR 052763A1
Authority
AR
Argentina
Prior art keywords
receiver
group
pharmaceutical compositions
tetrasubstituid
subtipe
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Josephus H M Lange
Hendrik C Wals
Cornelis G Kruse
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of AR052763A1 publication Critical patent/AR052763A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente se refiere a composiciones farmacéuticas. Reivindicacion 1: Compuestos de imidazol tetrasubstituidos, caracterizados por la formula general (1), donde: R1 representa un átomo de cloro, bromo, fluor o hidrogeno; R2 representa un átomo de cloro o bromo, o un grupo CF3; A representa un átomo de nitrogeno o un grupo CH; X representa un átomo de azufre o un grupo funcional sulfoxido (S=O) o un grupo funcional sulfona (SO2); Y representa un átomo de hidrogeno o un grupo metilo, etilo, n- propilo, isopropilo, n-butilo, t-butilo, trifluorometilo, fenilo, bencilo o piridilo; Z representa un átomo de nitrogeno o un grupo CH; n representa el valor 1, 2 o 3; y los tautomeros, estereoisomeros y sales farmacologicamente aceptables de los mismos.This refers to pharmaceutical compositions. Claim 1: Tetrasubstituted imidazole compounds, characterized by the general formula (1), wherein: R 1 represents a chlorine, bromine, fluorine or hydrogen atom; R2 represents a chlorine or bromine atom, or a CF3 group; A represents a nitrogen atom or a CH group; X represents a sulfur atom or a sulfoxide functional group (S = O) or a sulfone functional group (SO2); Y represents a hydrogen atom or a methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, trifluoromethyl, phenyl, benzyl or pyridyl group; Z represents a nitrogen atom or a CH group; n represents the value 1, 2 or 3; and tautomers, stereoisomers and pharmacologically acceptable salts thereof.

ARP050102138 2004-05-28 2005-05-24 TETRASUBSTITUID DERIVATIVES OF IMIDAZOL AS MODULATORS OF THE CANNABINOID CB1 RECEIVER WITH A HIGH SELECTIVITY FOR THE RECEIVER SUBTIPE CB1 / CB2. PHARMACEUTICAL COMPOSITIONS AR052763A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04076619 2004-05-28

Publications (1)

Publication Number Publication Date
AR052763A1 true AR052763A1 (en) 2007-04-04

Family

ID=34928258

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102138 AR052763A1 (en) 2004-05-28 2005-05-24 TETRASUBSTITUID DERIVATIVES OF IMIDAZOL AS MODULATORS OF THE CANNABINOID CB1 RECEIVER WITH A HIGH SELECTIVITY FOR THE RECEIVER SUBTIPE CB1 / CB2. PHARMACEUTICAL COMPOSITIONS

Country Status (5)

Country Link
CN (1) CN1956965B (en)
AR (1) AR052763A1 (en)
SA (1) SA05260148B1 (en)
TW (1) TW200608968A (en)
UA (1) UA85239C2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231757B (en) * 2001-09-21 2005-05-01 Solvay Pharm Bv 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity

Also Published As

Publication number Publication date
CN1956965A (en) 2007-05-02
SA05260148B1 (en) 2008-11-15
CN1956965B (en) 2011-03-23
TW200608968A (en) 2006-03-16
UA85239C2 (en) 2009-01-12

Similar Documents

Publication Publication Date Title
CO6140060A2 (en) DERIVATIVES OF AMINOCICLOALQUIL 1,2,4-TRIAZOL AS MODULATORS OF MGLUR5
AR057894A1 (en) THIOPHEN DERIVATIVES
AR057056A1 (en) PROCESS FOR SYNTHESIS OF IMIDAZOL BENCILAMINAS
PE20140968A1 (en) SUBSTITUTED BENZAMIDE DERIVATIVES
ATE455103T1 (en) PHENYLGLYCINAMIDE AND PYRIDYLGLYCINAMIDE DERIVATIVES USED AS ANTICOAGULATION AGENTS
PE20060770A1 (en) DERIVATIVES OF N - [(4,5-DIPHENYL-3-ALKYL-2-THENYL) METHYL] AMINE AS ANTAGONISTS OF CB1 CANNABINOID RECEPTORS
UY31507A1 (en) PIRIDINE DERIVATIVES SOLUBLE CYCLING GUANILATE ACTIVATORS
NO20075734L (en) Thiophene compounds and thrombopoietin receptor activators
PE20142282A1 (en) NEW ARYL-QUINOLINE DERIVATIVES
AR071385A1 (en) COMPOUNDS OF 2-IMINO-3-METHYL PIRROLOPIRIMIDINONE REPLACED WITH THIOPHENYLL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND USE OF THE SAME FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH THE BETA AMYLOID PROTEIN, SUCH AS ALZHEIMAS DE OMOSTER DE OMOS.
MA38540A1 (en) Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
RU2005117789A (en) 4,5-DIARYLTHIAZOLE DERIVATIVES AS SV-1 LIGANDS
DK1807434T3 (en) Thienopyridines as allosteric potentiators of the M4 muscarinic receptor
PE20080077A1 (en) SULFONYLPHENYL DERIVATIVES AS IL-8 RECEPTOR ANTAGONISTS
NO20061872L (en) Disulfide, sulfide, sulfoxide, and sulfo derivatives of cyclic sugars and their use
PE20060079A1 (en) PYRIDYL DERIVATIVES AS ANTAGONISTS OF THE mGlus5 RECEPTOR
AR054524A1 (en) METHODS AND DOSAGE FORMS TO REDUCE THE SIDE EFFECTS OF CARBAMATE COMPOUNDS
NO20072753L (en) 3-Ethylidene hydrazino-substituted heterocyclic compounds as thrombopoietin receptor activators
NO20060379L (en) The polymorphic form of 4- [6-acetyl-3- [3- (4-acetyl-3-hydroxy-2-propylphenylthio) propoxy] -2-propylphenoxybutanoic acid
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
WO2008155670A3 (en) Arylamide pyrimidone compounds
EA201070021A1 (en) METHOD OF SULFOXIDATION OF BIOLOGICALLY ACTIVE COMPOUNDS
DK1919896T3 (en) Aminoarylsulfonamide derivatives, as functional 5-HT6 ligands
PE20060696A1 (en) SOLUBLE ADENYLATE CYCLASE INHIBITORS
AR052763A1 (en) TETRASUBSTITUID DERIVATIVES OF IMIDAZOL AS MODULATORS OF THE CANNABINOID CB1 RECEIVER WITH A HIGH SELECTIVITY FOR THE RECEIVER SUBTIPE CB1 / CB2. PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal